| | |  | | | | Record from Web of Science® | | | | | | |
| Cancer vaccines based on the identification of genes encoding cancer regression antigens |
|
|
| Author(s): Rosenberg SA |
| Source: IMMUNOLOGY TODAY Volume: 18 Issue: 4 Pages: 175-182 Published: APR 1997 |
| Times Cited: 308 References: 59 |
| Abstract: The adoptive transfer of tumor-infiltrating lymphocytes (TILs) can mediate the regression of metastatic melanoma in humans. The genes encoding the antigens recognized by these TILs have been cloned and characterized. Here, Steven Rosenberg reviews how these genes and gene products are being used to develop new immunotherapies for the treatment of patients with cancer. |
| Document Type: Review |
| Language: English |
| Reprint Address: Rosenberg, SA (reprint author), NCI, NIH, BETHESDA, MD 20892 USA |
| Publisher: ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB |
| Subject Category: Immunology |
| IDS Number: WU363 |
| ISSN: 0167-5699 |
|
| | | | | | | | | Record from Web of Science® | | | | | | | | | |